Desensitization of beta1 adrenergic receptor-nitric oxide signaling in cardiac diseases
心脏病中β1肾上腺素受体-一氧化氮信号的脱敏
基本信息
- 批准号:10618826
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2025-09-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdrenergic AgentsAdrenergic ReceptorAgonistAttenuatedBindingBiochemistryBiological AssayBiosensorC-terminalCalciumCardiacCardiac OutputCardiomyopathiesChronicCo-ImmunoprecipitationsComplexCouplingCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic GMPCyclic GMP-Dependent Protein KinasesDataDiseaseDissociationElectrophysiology (science)Enzyme-Linked Immunosorbent AssayEpinephrineFluorescence Resonance Energy TransferFluorescent DyesFunctional disorderG-substrateGTP-Binding ProteinsHealthHeartHeart DiseasesHeart failureHumanImpairmentIndividualKnock-inKnock-outKnockout MiceKnowledgeMuscle CellsMyocardialMyocardial InfarctionMyocardial dysfunctionNOS1 geneNOS3 geneNitric OxideNitric Oxide SynthaseOpticsPathway interactionsPhosphorylationPhosphotransferasesPhysiologicalPlayProteinsReceptor SignalingRecoveryRegulationResearchRoleRyanodine Receptor Calcium Release ChannelScaffolding ProteinSerineSignal TransductionSignaling MoleculeSoluble Guanylate CyclaseStressSynapsesSynaptic ReceptorsTechniquesTestingTransgenic MiceTransgenic Organismsadrenergic stressaorta constrictiondesensitizationheart functionheart preservationin vivoinhibitorinnovationnovelnovel strategiesphosphodiesterase 4Dphospholambanpreservationreceptorrestoration
项目摘要
Emerging evidence indicates that nitric oxide (NO) is involved in cardiac β1 adrenergic receptor
(β1AR) stimulation of cardiac function. We propose that scaffold protein SAP97 plays a critical
role in regulation of cardiac β1AR-induced NOS1-NO signaling cascade via organizing a β1AR-
NOS1 signalosome. This pathway is necessary for regulation of cardiac contractile function. We
also hypothesize that G-protein kinase 5 (GRK5) promotes phosphorylation of cardiac β1AR
PDZ motif and dissociation of the receptor from the SAP97-organized signalosome for activation
of NOS1-NO signaling and promotes desensitization of receptor signaling in cardiac diseases.
We will test the hypotheses with the following aims. Aim 1. SAP97 regulates β1AR-induced NO
signaling in heart. Aim 2. SAP97 maintains the integrity of β1AR-SAP97-NOS1 signalosome to
preserve cardiac function. Aim 3. GRK5 promotes desensitization of β1AR-NO signaling via
disruption of the receptor-SAP97 signalosome in heart failure.
新的证据表明,一氧化氮(NO)参与心脏β1肾上腺素能受体
(β 1 AR)刺激心脏功能。我们认为,支架蛋白SAP 97起着关键作用,
β 1 AR-1在调节心脏β 1 AR诱导的NOS 1-NO信号级联中的作用
NOS 1信号体。该途径对于调节心脏收缩功能是必需的。我们
还假设G蛋白激酶5(GRK 5)促进心脏β 1 AR的磷酸化
PDZ基序和受体从SAP 97组织的信号体上解离以激活
NOS 1-NO信号转导的抑制作用,并促进心脏疾病中受体信号转导的脱敏。
我们将以下列目标来检验这些假设。目标1。SAP 97对β 1AR诱导的NO的调节作用
在心里发出信号。目标2. SAP 97保持β 1AR-SAP 97-NOS 1信号体的完整性,
保护心脏功能。目标3. GRK 5通过介导β1AR-NO信号转导促进脱敏
心力衰竭中SAP 97受体信号体的破坏。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YANG K XIANG其他文献
YANG K XIANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YANG K XIANG', 18)}}的其他基金
Phosphodiesterases govern nuclear cAMP signaling for gene expression
磷酸二酯酶控制基因表达的核 cAMP 信号传导
- 批准号:
10717183 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Desensitization of beta1 adrenergic receptor-nitric oxide signaling in cardiac diseases
心脏病中β1肾上腺素受体-一氧化氮信号的脱敏
- 批准号:
10367949 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Molecular Regulation of cardiac adrenergic signaling
心脏肾上腺素信号传导的分子调节
- 批准号:
10425249 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Molecular Regulation of cardiac adrenergic signaling
心脏肾上腺素信号传导的分子调节
- 批准号:
9922716 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Molecular Regulation of cardiac adrenergic signaling
心脏肾上腺素信号传导的分子调节
- 批准号:
10155584 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Novel mechanism on subpopulation-dependent biased GPCR signaling in neurons
神经元亚群依赖性偏向 GPCR 信号传导的新机制
- 批准号:
10174956 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Novel mechanism on subpopulation-dependent biased GPCR signaling in neurons
神经元亚群依赖性偏向 GPCR 信号传导的新机制
- 批准号:
9929881 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Novel mechanism on subpopulation-dependent biased GPCR signaling in neurons
神经元亚群依赖性偏向 GPCR 信号传导的新机制
- 批准号:
10372289 - 财政年份:2018
- 资助金额:
-- - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
-- - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
-- - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
-- - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
-- - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
-- - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
-- - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
-- - 项目类别:














{{item.name}}会员




